Skip to main content Accessibility help
×
Home

The use of nicorandil in cardioplegia solution

  • G. Kiss (a1), G. Gueret (a1), O. Corre (a1), R. Deredec (a1) and C. C. Arvieux (a1)...
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The use of nicorandil in cardioplegia solution
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The use of nicorandil in cardioplegia solution
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The use of nicorandil in cardioplegia solution
      Available formats
      ×

Abstract

  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.

Copyright

Corresponding author

University Hospital of Brest, Anaesthesia and Surgical Intensive Care, Bd. Tanguy Prigent, Brest, France. E-mail: gaborkiss2001@hotmail.com; Tel: +33 2 98 34 74 28; Fax: +33 2 98 34 74 41

References

Hide All
1.Chinnan, NK, Puri, GD, Thingnam, SK. Myocardial protection by nicorandil during open-heart surgery under cardiopulmonary bypass. Eur J Anaesthesiol 2007; 24: 2632.
2.Lopez, JR, Jahangir, R, Jahangir, A, Shen, WK, Terzic, A. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia. J Thorac Cardiovasc Surg 1996; 112: 820831.
3.Nishizaki, M, Arita, M, Sakurada, H et al. . Induction of polymorphic ventricular tachycardia by programmed ventricular stimulation in vasospastic angina pectoris. Am J Cardiol 1996; 77: 355360.
4.Iida, R, Yazaki, S, Saeki, S, Ogawa, S. Recurrent ST-segment elevations in a patient without significant coronary disease. Clin Anesth 2005; 17: 372378.
5.Mehta, AC, Rafanan, AL, Bulkley, R, Walsh, M, DeBoer, GE. Coronary spasm and cardiac arrest from carcinoid crisis during laser bronchoscopy. Chest 1999; 115: 598600.
6.Cohen, G, Borger, MA, Weisel, RD, Rao, V. Intraoperative myocardial protection: current trends and future perspectives. Ann Thorac Surg 1999; 68: 19952001.

The use of nicorandil in cardioplegia solution

  • G. Kiss (a1), G. Gueret (a1), O. Corre (a1), R. Deredec (a1) and C. C. Arvieux (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.